Dezhan Ebit from 2010 to 2025

000813 Stock   3.00  0.05  1.64%   
Dezhan HealthCare's EBIT is decreasing over the years with slightly volatile fluctuation. Overall, EBIT is projected to go to about -40.4 M this year. From 2010 to 2025 Dezhan HealthCare EBIT quarterly data regression line had arithmetic mean of  432,601,096 and r-squared of  0.55. View All Fundamentals
 
EBIT  
First Reported
2018-06-30
Previous Quarter
-28.8 M
Current Value
-1.6 M
Quarterly Volatility
104.8 M
 
Covid
Check Dezhan HealthCare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dezhan HealthCare's main balance sheet or income statement drivers, such as Interest Expense of 441.8 K, Selling General Administrative of 278.5 M or Total Revenue of 831.1 M, as well as many indicators such as . Dezhan financial statements analysis is a perfect complement when working with Dezhan HealthCare Valuation or Volatility modules.
  
This module can also supplement various Dezhan HealthCare Technical models . Check out the analysis of Dezhan HealthCare Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Dezhan Stock

Dezhan HealthCare financial ratios help investors to determine whether Dezhan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dezhan with respect to the benefits of owning Dezhan HealthCare security.